Relay Therapeutics, Inc. RLAY Q2 2025 earnings
Reported August 7, 2025 · After market close
Revenue$677.0KBeat by $662.7K
EPS-$0.41Beat by $0.08
Revenue estimate$14.3K
EPS estimate-$0.49
Next report
Aug 6, 2026 (In 1 week)Revenue estimate$960.0K
EPS estimate-$0.41
Financials
Q2 2025Valuation & ratios
Versus estimates
Revenue
Q1 2026$3.0MMiss by $2.6MQ4 2025$7.0MBeat by $2.0M
Q2 2025$677.0KBeat by $662.7K
Q1 2025$7.7MBeat by $3.9MDiluted EPS
Ask the moment Relay Therapeutics, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Relay Therapeutics, Inc. report Q2 2025 earnings?
- Relay Therapeutics, Inc. (RLAY) reported Q2 2025 earnings on August 7, 2025 after market close.
- What were Relay Therapeutics, Inc.'s Q2 2025 revenue and EPS?
- Relay Therapeutics, Inc. reported revenue of $677.0K and eps of $-0.41 for Q2 2025.
- Did Relay Therapeutics, Inc. beat estimates in Q2 2025?
- Revenue beat the consensus estimate of $14.3K by $662.7K. EPS beat the consensus estimate of $-0.49 by $0.08.
- How did Relay Therapeutics, Inc.'s Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 40.6% from $-0.69.
- Where can I find Relay Therapeutics, Inc.'s Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0000950170-25-105054) directly on SEC EDGAR. The filing index links above go to sec.gov.